CN104857208A - Mixed traditional Chinese medicine for treating hemorrhagic glaucoma - Google Patents

Mixed traditional Chinese medicine for treating hemorrhagic glaucoma Download PDF

Info

Publication number
CN104857208A
CN104857208A CN201510275431.3A CN201510275431A CN104857208A CN 104857208 A CN104857208 A CN 104857208A CN 201510275431 A CN201510275431 A CN 201510275431A CN 104857208 A CN104857208 A CN 104857208A
Authority
CN
China
Prior art keywords
parts
grams
chinese medicine
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510275431.3A
Other languages
Chinese (zh)
Inventor
劳炳凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510275431.3A priority Critical patent/CN104857208A/en
Publication of CN104857208A publication Critical patent/CN104857208A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a mixed traditional Chinese medicine for treating hemorrhagic glaucoma. The traditional Chinese medicine is mainly prepared by mixing the following traditional Chinese medicines in parts by weight: 10 parts of abalone shells, 10 parts of asarum, 10 parts of divaricate saposhnikovia roots, 10 parts of antelope horns, 10 parts of giant typhonium rhizomes, 10 parts of Chinese thorowax, 10 parts of safflowers, 8 parts herba lycopi, 8 parts of ligusticum wallichii, 5 parts of Chinese rhubarb, 12 parts of plantain seed, 10 parts of radix achyranthis bidentatae, and 3 parts of radix notoginseng powder. The mixed traditional Chinese medicine for treating the hemorrhagic glaucoma analyzes the pathogenesis of the hemorrhagic glaucoma according to the traditional Chinese medicine, and adopts medicines for clearing heat, expelling blood stasis and regulating the meridians for cooperation treatment, so that an obvious stable curative effect can be achieved.

Description

The mixing Chinese medicine for the treatment of neovascular glaucoma
Technical field
the present invention relates to the Chinese medicine for the treatment of neovascular glaucoma, belong to medicine technology field.
Background technology
hemorrhagicglaucoma (NVG) suffers from eye iris also exists new vessels.Until entered for 20th century, the knowledge about NVG is just based upon in perfect anatomical basis.1906, Coats described central retinal vein occlusion, and the histology suffering from new vessels on iris in eye finds.Nineteen twenty-eight, Salus describes new vessels similar on iris in patient of diabetes eye.20th century are early stage, and after gonioscopy method introduces clinical practice, Kurz thinks that the contraction of connective tissue is the reason causing angle, adhesive room to close.In view of this glaucomatous cause is new vessels instead of intraocular hemorrhage, Weiss equals the title that 1963 propose neovascular glaucoma.Eye is congested, and corneal edema, violent ophthalmalgia, headache, often cause blind.Iris neovascularization is often secondary to the disease that some causes Retinal hypoxia, as central retinal vein occlusion, diabetic retinopathy, central retinal artery occlusion, periphlebitis of retina, malignant melanoma, retinoblastoma, detachment of retina and cranial arteritis etc., especially more common with first two disease.Clinical characters is that new vessels appears in iris on constitutional oculopathy basis, and disease is in earlier stage because fibrovascular membranes encloses ah outflow passage, and later stage fibrovascular membranes shrinks tractive, and angle, room is closed, and causes intraocular pressure raise and have an intense pain.
Treatment hemorrhagicglaucoma can adopt operation, and conventional filtering surgery is failure usually, and preoperative panretinal photocoagulation or cryocoagulation make new vessels degenerate, or in art, postoperative application antimetabolite can improve success rate of operation.Aqueous humor drainage device or valve implant surgery are also used for the treatment of neovascular glaucoma in recent years.If said method failure, can consider that ciliary body destroy operation reduces house water and formed, reduce intraocular pressure with relief of symptoms.Retinal hypoxia and blood capillary are the roots of rubeosis without concern, have ischemia phenomenon to make panretinal photocoagulation, to prevent the generation of iris neovascularization once discovery retina.
Summary of the invention
In order to overcome operative treatment hemorrhagicglaucomatous shortcoming, the invention provides a kind of through treatment by Chinese herbs hemorrhagethe glaucomatous Chinese medicine composition medicament of property.Chinese medicine is thought, hemorrhageproperty glaucoma mostly be because flaming up of liver-fire, disturbing upward of liver-fire, wind-fire invading eye, steaming are burnt order network, or wind-phlegm is stopped up, blocks order network, or qi depression to blood stasis, sweat pore obstruction, the refreshing water stasis of blood is long-pending and send out as primary disease.Treatment hemorrhagicglaucoma.Should stop burning with liver heat removing, heat clearing away of invigorating blood circulation, lowering fire and expelling phlegm, blood circulation promoting and blood stasis dispelling Chinese Medicine and Clavicular treatment.
Treatment hemorrhagicthe technical scheme that glaucomatous mixing Chinese medicine is taked mixes by each Chinese medicine quality ratio below: Concha Haliotidis 10 parts, Herba Asari 10 parts, Radix Saposhnikoviae 10 parts, Cornu Saigae Tataricae 10 parts, Rhizoma Typhonii 10 parts, Radix Bupleuri 10 parts, 10 parts, Flos Carthami, Herba Lycopi 8 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 5 parts, Semen Plantaginis 12 parts, Radix Achyranthis Bidentatae 10 parts, Radix Notoginseng powder 3 parts.
analyze one by one belowtreatment hemorrhagicglaucoma in each herbal nature drug effect.concha Haliotidis is Mollusca Bao Lei section, and the shell of animal Haliotis diversicolor (haliotis diversicolor Reeve) Bao, haliotis ruber, Er Bao or white Bao, summer, Qiu Erji catch, and fleshing, cleaning, drying, have calming liver and clearing heat, effect of improving eyesight removing nebula.Herba Asari can outer dispersing wind and cold, again can in dispel YIN-cold, pain relieving simultaneously, antitussive effect are better, though Herba Asari has good cold expelling effect, perspiration power is more weak, does not make principal agent in the prescription that generally induces sweat.Radix Saposhnikoviae, chief of a tribe's name in old legend; Also being the name of a kind of medicinal herbs, is the root of Umbelliferae herbaceos perennial Radix Saposhnikoviae, main product in Heilungkiang, Sichuan, the ground such as Inner Mongol, raw use, Radix Saposhnikoviae has another name called that copper rues, Rhizoma Cibotii, and for delivering, dispel the wind, victory is wet, pain relieving. control affection of exogenous wind-cold, headache, dizzy.Cornu Saigae Tataricae is a kind of precious Chinese medicine material, has suppressing the hyperactive liver to relieve the wind syndrome, loose blood removing toxic substances, liver heat removing and eyesight improving effect. modern study shows, Cornu Saigae Tataricae powder has antipyretic, calm and anticonvulsant action.Radix Bupleuri clearind deficient heat Chinese medicine, comes off for cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus, menoxenia.Rhizoma Typhonii energy brain-strengthening, strong muscle, bone strengthening, logical blood, anti-inflammatory analgetic, regulating menstruation.Flos Carthami is warm in nature, acrid in the mouth, latus rectum of invigorating blood circulation, eliminating stasis to stop pain, and for amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury, be suitable for various varicosis, peripheral neuritis, blood circulation is bad, lower limb numbness or the congestion such as livid purple.Herba Lycopi: blood circulation promoting and blood stasis dispelling; Line water detumescence; Removing toxicity for eliminating carbuncles, housewife female's amenorrhea; Dysmenorrhea; The stagnant stomachache of the stasis of blood in puerperal; Lump in the abdomen edema; Traumatic injury; Carbuncle sore tumefacting virus, for menoxenia, amenorrhea, dysmenorrhea, postnatal blood stasis is suffered from abdominal pain, edema.The effect of Rhizoma Chuanxiong blood and dissolving stasis is extensive, the suitable various disease of stagnation of blood stasis; Wind-expelling pain-stopping, effectiveness is excellent, can control the diseases such as wind syndrome of head headache, rheumatic arthralgia.Radix Et Rhizoma Rhei is used for purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.For excess-heat constipation, stagnant stomachache, dysentery is not well, jaundice due to damp-heat, and heat in blood tells nosebleed, conjunctival congestion, pharyngeal swelling, abdominalgia with intestinal abscess, carbuncle furuncle, blood stasis amenorrhea, traumatic injury, and external treatment extreme misery scalds.It is real that Semen Plantaginis has another name called Herba Plantaginis, Semen Plantaginis sweet in the mouth, light, cold nature; Return kidney, bladder, liver, lung meridian; Matter downhill race profit; There is clearing away heat and promoting diuresis, effect that improving eyesight is eliminated the phlegm.Effect of Radix Achyranthis Bidentatae: soreness of waist and knee joint; Flaccidity and weakness of the lower limbs; Amenorrhea due to stagnation of blood; Dysmenorrhea; Puerperal abdominal pain due to blood stasis; Note of the ancient Chinese abdominal mass; Retention of placenta; Pyretic stranguria; Stranguria with blood; Traumatic injury; Carbuncle malignant boil; Laryngopharynx swelling and pain.Radix Notoginseng powder can stop blooding, dissipating blood stasis, detumescence, analgesic therapy.Control haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia , mass in the abdomen, puerperal blood faints, retention of lochia, falls and flutters blood stasis, traumatic hemorrhage, carbuncle pain.
Treatment hemorrhagicglaucomatous beneficial effect is: treatment neovascular glaucoma Chinese medicine so that wind-fire invading eye, wind-phlegm to be disturbed, qi depression to blood stasis, do that pathogeny is dialectical to be treated, stop burning with liver heat removing, heat clearing away of invigorating blood circulation, lowering fire and expelling phlegm, blood circulation promoting and blood stasis dispelling Chinese Medicine and Clavicular treatment, receive stable curative effect.
Detailed description of the invention
Treatment hemorrhagicthe dosage that glaucoma neovascular glaucoma patient takes mixes by each Chinese medicine quality ratio below: Concha Haliotidis 10 grams, Herba Asari 10 grams, Radix Saposhnikoviae 10 grams, Cornu Saigae Tataricae 10 grams, Rhizoma Typhonii 10 grams, Radix Bupleuri 10 grams, 10 grams, Flos Carthami, Herba Lycopi 8 grams, Rhizoma Chuanxiong 8 grams, Radix Et Rhizoma Rhei 5 grams, Semen Plantaginis 12 grams, Radix Achyranthis Bidentatae 10 grams, Radix Notoginseng powder 3 grams.
Treatment hemorrhagicglaucomatous using method: reach moistening in 2 hours by soaking with clear water after each Effect of Chinese Medicine Qing wash clean, then decoct with clear water, the middle dose of a dosage coordinates clear water 1.5 premium on currency, carries out the separation of slag liquid, obtain medicinal liquid and be medicament after decocting for 1 half an hour.Severe patient one day dosage, natural gift three times take, and are used in conjunction use of can cutting down according to the circumstance in a week.

Claims (2)

1. treat hemorrhagicglaucomatous mixing Chinese medicine, is characterized in that mixing by each Chinese medicine quality ratio below: Concha Haliotidis 10 parts, Herba Asari 10 parts, Radix Saposhnikoviae 10 parts, Cornu Saigae Tataricae 10 parts, Rhizoma Typhonii 10 parts, Radix Bupleuri 10 parts, 10 parts, Flos Carthami, Herba Lycopi 8 parts, Rhizoma Chuanxiong 8 parts, Radix Et Rhizoma Rhei 5 parts, Semen Plantaginis 12 parts, Radix Achyranthis Bidentatae 10 parts, Radix Notoginseng powder 3 parts.
2. treatment according to claim 1 hemorrhagicglaucomatous mixing Chinese medicine, is characterized in that: the dosage that neovascular glaucoma patient takes mixes by each Chinese medicine quality ratio below: Concha Haliotidis 10 grams, Herba Asari 10 grams, Radix Saposhnikoviae 10 grams, Cornu Saigae Tataricae 10 grams, Rhizoma Typhonii 10 grams, Radix Bupleuri 10 grams, 10 grams, Flos Carthami, Herba Lycopi 8 grams, Rhizoma Chuanxiong 8 grams, Radix Et Rhizoma Rhei 5 grams, Semen Plantaginis 12 grams, Radix Achyranthis Bidentatae 10 grams, Radix Notoginseng powder 3 grams.
CN201510275431.3A 2015-05-27 2015-05-27 Mixed traditional Chinese medicine for treating hemorrhagic glaucoma Withdrawn CN104857208A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510275431.3A CN104857208A (en) 2015-05-27 2015-05-27 Mixed traditional Chinese medicine for treating hemorrhagic glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510275431.3A CN104857208A (en) 2015-05-27 2015-05-27 Mixed traditional Chinese medicine for treating hemorrhagic glaucoma

Publications (1)

Publication Number Publication Date
CN104857208A true CN104857208A (en) 2015-08-26

Family

ID=53903673

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510275431.3A Withdrawn CN104857208A (en) 2015-05-27 2015-05-27 Mixed traditional Chinese medicine for treating hemorrhagic glaucoma

Country Status (1)

Country Link
CN (1) CN104857208A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579840A (en) * 2012-03-26 2012-07-18 许梅 Chinese medicinal composition with effects of reducing intraocular pressure and protecting optic nerves and preparation method thereof
CN104398885A (en) * 2014-11-24 2015-03-11 毛华养 Traditional Chinese medicament for treating neovascular glaucoma
CN104398947A (en) * 2014-11-18 2015-03-11 李殿光 Traditional Chinese medicine preparation for treating glaucoma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579840A (en) * 2012-03-26 2012-07-18 许梅 Chinese medicinal composition with effects of reducing intraocular pressure and protecting optic nerves and preparation method thereof
CN104398947A (en) * 2014-11-18 2015-03-11 李殿光 Traditional Chinese medicine preparation for treating glaucoma
CN104398885A (en) * 2014-11-24 2015-03-11 毛华养 Traditional Chinese medicament for treating neovascular glaucoma

Similar Documents

Publication Publication Date Title
CN101564521B (en) External plaster for treating hyperplasia of mammary glands
CN102579918B (en) Traditional Chinese medicine composition for treating glaucoma as well as preparation method and administration mode of same
CN102793883B (en) Plaster for treating intervertebral disc protrusion and cervical spondylosis
CN103656290B (en) Medicine for treating optic atrophy and preparation method of medicine
CN102579715B (en) Chinese medicinal composition for treating hydrocephalus and preparation method thereof
CN102357235A (en) Pasty pharmaceutical composition and preparation method thereof
CN103784591A (en) Traditional Chinese medicine composition for postpartum care
CN103495055A (en) Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof
CN105362711A (en) Plaster for treating pain of bone injury and preparation method thereof
CN102949569A (en) Traditional Chinese medicine composition for treating frequent micturition, urgent urination and micturition pain caused by benign prostatic hyperplasia
CN102302740A (en) Preparation method of traditional Chinese medicine used for treating thoracic obstructions caused by yin deficiency of heart and kidney
CN101703625B (en) Oral Chinese medicinal composition for treating glaucoma
CN101269160B (en) Chinese medicinal composition for treating trigeminal neuralgia
CN103142787A (en) Plaster for treating facial paralysis and preparation method thereof
CN101204451B (en) Peroral Chinese traditional medicine prescription for glaucoma
CN105194427A (en) Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese composition
CN104857208A (en) Mixed traditional Chinese medicine for treating hemorrhagic glaucoma
CN104383152A (en) Traditional Chinese medicine preparation for treating glaucoma and preparation method of traditional Chinese medicine preparation
CN104288518A (en) Traditional Chinese medicine composition for treating cervicitis
CN104398885A (en) Traditional Chinese medicament for treating neovascular glaucoma
CN104258017A (en) Mixed traditional Chinese medicine for treating malignant glaucoma
CN103610797B (en) Traditional Chinese medicine composition for treating keratoconjunctivitis due to congestion and excess of dampness-heat
CN102688456B (en) Chinese medicinal composition for treating chronic prostatitis
CN102114140A (en) Chinese medicine oral decoction for treating endometriosis
CN103127352B (en) Chinese medicine composition for treating blood stasis type irregular menstruation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20150826